Editorial Staff

  • Clinical Editor:

    Morton Kern, MD
  • Executive Editor:

    Laurie Gustafson
  • Managing Editor:

    Rebecca Kapur
  • Production Manager:

    Elizabeth Vasil
  • Editorial Correspondence

  • Rebecca Kapur, Managing Editor, Cath Lab Digest
  • HMP Communications, 83 General Warren Blvd

    Suite 100, Malvern PA 19355
  • Telephone: (800) 459-8657

    Fax: (866) 896-8762
  • Email: rkapur@hmpcommunications.com
  • June, 2004
    Volume 12
    Issue 6


    There is some controversy over the role(s) available in the cath lab for different credentials and just to what extent they can and should be cross-trained. What do you feel are the proper role(s) or responsibilities for RNs, RCISs, and RT(R)s in the cath lab? What about other credentials like physician assistants (PAs)?

    CVT Program is valuable

    I am currently in school for a CVT program and I think what has been taught through the school is more beneficial than being trained on the job. With the CVT program, you learn about diagnosing and more preventio

    continue reading
    Volume 12 - Issue 6 - June, 2004   |   1,640 reads

    Sameer Mehta, MD, FACC, Director Cardiac Cath Lab, Samir M. Yebara, MD, Mohammed Ibrahim, MD, Martha Reyes, MD, Mercy Medical Center, Miami, Florida; Annmarie Galli, BSN, MBA, The Medicines Company, Parsippany, New Jersey

    It is now widely accepted that early sheath removal after percutaneous coronary intervention (PCI) reduces femoral access site complications and leads to earlier ambulation, possibly earlier discharge, and improved patient satisfaction. Heparin-based anticoagulation therapy requires monitoring of coagulation status to determine readiness for sheath removal, due to the unpredictable nature of heparin. In an effort to increase quality of care for his patients undergoing PCI, as well as reduce the cost of resources in the cath lab, Dr. Sameer Mehta developed a time-based sheath removal proto

    continue reading
    Volume 12 - Issue 6 - June, 2004   |   12,532 reads

    Abbott Vascular Devices Launches Perclose® ProGlide Next Generation Suture-Mediated Vessel Closure System

    Abbott Vascular Devices, a division of Abbott Laboratories, announced the launch of the next generation Perclose® suture-mediated vessel closure system, Perclose ProGlide, featuring polypropylene monofilament suture. The device received approval from the U.S. Food and Drug Administration (FDA) during the first quarter of 2004. Perclose closure devices are designed to close femoral artery puncture sites following diagnostic or interventional procedures.

    With monofilament

    continue reading
    Volume 12 - Issue 6 - June, 2004   |   12,677 reads

    Elisabeth M. Frails, RCVT/RCIS, Cardiovascular Educator, University Hospital, Augusta, Georgia

    Those of us who have been in the cath lab setting for the past 15 years or more have witnessed dramatic changes, the majority of which are for the better, but some of which we may not be too sure. However, there are certainly many positive developments which have resulted in an improved work environment, such as streamlined operations, identification and definition of specific accountabilities and responsibilities, and a redefining of the team concept. Positive changes have also occurred in imaging technology, as well as with device improvements, such as drug-eluting stents and plaque abl

    continue reading
    Volume 12 - Issue 6 - June, 2004   |   2,304 reads

    Atul Sharma, MD and S.Chiu Wong, MD, Maurice R. and Corinne P. Greenberg Division of Cardiology
    Department of Medicine, The New York Presbyterian Hospital-Weill Cornell Medical College, New York, New York

    This presentation contains discussion of published and/or investigational uses of agents that are not indicated by the FDA. Neither the North American Center for Continuing Medical Education nor Cordis Corporation recommends the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

    Topics: The Impact of Sirolimus-Eluting Stents on Patients at High Risk for Restenosis with Bare Metal Stenting

    Faculty/Credentials: Atul Sharma, MD and S.C

    continue reading
    Volume 12 - Issue 6 - June, 2004   |   4,869 reads

    This image was taken by Dr. Jason H Rogers, Assistant Clinical Professor, Cardiovascular Medicine; University of California Davis Medical Center, Sacramento, California.

    continue reading
    Volume 12 - Issue 6 - June, 2004   |   2,542 reads

    Coleman DeMoss, RA, Principal, Perkins & Will, Atlanta, Georgia

    Smaller, sleeker technologies in conjunction with increasingly sophisticated medical procedures have changed the face of cardiac catheterization labs.

    Changing Spaces

    In the above floor plans, which represent a health care provider both in the mid-1990’s and today, we can compare and contrast the way in which cardiac cath labs have changed over the past 10 years. While lab configuration has not changed radically, subtle differences in design can allow a lab to operate more efficiently.

    Central to the design of modern cath labs is the shrinking of electronic e

    continue reading
    Volume 12 - Issue 6 - June, 2004   |   13,193 reads

    Rebecca Yospyn
    Managing Editor

    I am honored to acknowledge all Cath Lab Digest Annual Symposium on Cardiovascular Care (ASOCC) attendees in Orlando, Florida, June 3-5. Thank you for attending ASOCC! The Cath Lab Digest Annual Symposium provides a chance to learn, network and ask questions of the experts our engaging, experienced faculty and your fellow professionals, who just may have the hands-on knowledge you’re looking for. ASOCC attendees also received a unique bumper sticker:

    If you weren’t able to make it to ASOCC this year, I hope to see you in 2005!

    This month, Cath Lab Digest serves up the latest in

    continue reading
    Volume 12 - Issue 6 - June, 2004   |   1,642 reads